Compare Mayora Indah Tbk. (MYOR) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mayora Indah Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mayora Indah Tbk. trades at Rp1,515 (market cap 34.21T, 23.47M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mayora Indah Tbk. is far larger — about 327.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MYOR | SCPI | |
|---|---|---|
Market Cap | 34.21T | 104.4B |
Volume | 23.47M | — |
Lot | 234.67K | — |
Turnover | 35.38B | — |
Average Price | 1,507.67 | — |
Value | 35.38B | — |
Indicative Equilibrium Price | 1,515 | — |
Indicative Equilibrium Volume | 3.97K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mayora Indah Tbk.
PT Mayora Indah Tbk (the Company) was established on February 17, 1977 is well known as one of the largest domestic manufacturers and producers of processed food in Indonesia. It was listed on the Jakarta and Surabaya Stock Exchange in May 1990. PT Mayora and its subsidiaries produce variety of consumer foods such as biscuits, wafers, candies, chocolate products, cocoa and coffee products.
Read more on MYOR →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
